Introduction: The COVID-19 caused by novel single-stranded RNA enveloped severe acute respiratory syndrome coronavirus-2 first appeared in Wuhan, China. Presence of cardiovascular complication had shown to be a significant contributor of increased fatality in COVID-19 patients. Cardiac injury was seen in studies reported from the national health commission which reported elevated T-troponin (TnT) levels and/or new onset of electrocardiographic (ECG) /echocardiographic abnormalities in COVID-19 recovered patients. Hence, this study evaluated the cardiac changes in recovered COVID-19 positive patients by 2D echocardiogram. Material and Methods: In this prospective, observational study, 139 participants recovered from COVID-19 illness were identified and recruited after obtaining the Informed concerned form. The patients once enrolled were subjected to 2D echo and ECG as part of routine clinical practice. Results: Among 139 patients, 89 (64.03%) were males and the rest were females. Based on severity scale 13 (9.35%) participants had suffered severe form of COVID-19 infection. Left ventricular ejection fraction (LVEF%) was found to be normal in all the 139 participants. Left ventricular global strain (LVGLS) was found to be abnormal in 70 (50.36%) participants. Similarly on right ventricular functional assessment, right ventricular global strain (RVGLS) was found to be abnormal in 72 (51.80%) participants. Arrythmias was reported in 31 (22.30%) participants, among them 30 participants had sinus bradycardia. Conclusion: Our study demonstrates the association between COVID-19 and cardiac changes/ incidence of cardiovascular complications in recovered COVID-19 patients and provides first hand evidence of the incidence of abnormal LVGLS and RVGLS in COVID-19 recovered patients